Skip to main content
Earnings Labs
Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc. (SUPN) Earnings

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic

$26.43

+1.03%

Mkt Cap $2.11B

EPS — Estimate vs Actual

Mkt Cap

$2.11B

P/E

—

Fwd P/E

25.99

P/S

2.72

Rev TTM

—

EPS TTM

-$0.51